Allarity Therapeutics ALLR
NASDAQ ALLR
$0.94 -0.02 (-2.08%)
At close: Nov 9, 2026 · 4:00 PM EST

Allarity Therapeutics (ALLR) Long-Term Debt Repayments (2020 - 2023)

Updated

Allarity Therapeutics' Long-Term Debt Repayments came in at $1.34 million for FY2024, down 63.8% from $3.7 million in FY2023.

Analysis

Allarity Therapeutics (ALLR) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends

Going back to FY2020, Allarity Therapeutics' Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a four-year compound annual growth rate of 25.9% (FY2020 to FY2024).
  • The FY2024 figure represents the lowest annual Long-Term Debt Repayments since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $3.7 million in FY2023, $2.95 million in FY2021 (+452.5%) and $533,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 1.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Allarity Therapeutics 14.97 Mn -53.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1,000.00
Sep 30, 2023 350,000.00
Dec 31, 2021 11,000.00
Sep 30, 2021 -10,000.00
Dec 31, 2020 -3,000.00
API Access

Allarity Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ALLR&period=max&api_key=YOUR_API_KEY